Previously Treated Recurrent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Previously Treated Recurrent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Previously Treated Recurrent Today - Breaking & Trending Today

Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China

Published: June 29, 2022

Globally first dual immune checkpoint inhibitor bi-specific antibody approved for marketing China's first immunotherapy bi-specific antibody approved for...

Source: prnewswire.com

Related Topics:

Jing WangMichelle XiaWang JingWu XiaohuaXiaohua WuPrnewswire Akeso IncChina Medical Products AdministrationCancer Hospital Affiliated To Fudan UniversityRadiography Review CommitteeSociety Of Gynecologic OncologyAkeso IncGynecologic OncologyObjective Response RateIndependent Radiography Review CommitteeProgression Free SurvivalOverall SurvivalProfessor Wu XiaohuaCancer Hospital AffiliatedProfessor Wang JingVice PresidentHunan CancerProfessor WangPreviously Treated RecurrentCervical Cancer